With 2.43 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.67 million shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $35.9281 whereas the lowest price it dropped to was $34.35. The 52-week range on TEM shows that it touched its highest point at $79.49 and its lowest point at $22.89 during that stretch. It currently has a 1-year price target of $56.89.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of TEM was down-trending over the past week, with a drop of -6.32%, but this was down by -11.86% over a month. Three-month performance dropped to -28.34% while six-month performance fell -12.43%.
Float and Shares Shorts:
At present, 150.28 million TEM shares are outstanding with a float of 49.10 million shares on hand for trading. On 2024-12-31, short shares totaled 8.73 million, which was 554.0 higher than short shares on 1732838400. In addition to Mr. Eric P. Lefkofsky as the firm’s Co-Founder, CEO, President & Chairman, Mr. James Rogers serves as its Chief Financial Officer.
Institutional Ownership:
Through their ownership of 0.30787 of TEM’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, TEM reported revenue of $180929000.0 and operating income of -$53616000.0. The EBITDA in the recently reported quarter was -$50909000.0 and diluted EPS was -$0.46.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for TEM since 6 analysts follow the stock currently. There are 6 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With TEM analysts setting a high price target of 70.0 and a low target of 50.0, the average target price over the next 12 months is 56.88889. Based on these targets, TEM could surge 99.15% to reach the target high and rise by 42.25% to reach the target low. Reaching the average price target will result in a growth of 61.85% from current levels.
Analysts have provided yearly estimates in a range of -$1.12 being high and -$2.04 being low. For TEM, this leads to a yearly average estimate of -$1.51.
